April 7 (Reuters) - Aerovate Therapeutics Inc AVTE.O:
AEROVATE THERAPEUTICS ANNOUNCES RANGE OF EXPECTED CASH DIVIDEND IN CONNECTION WITH THE PROPOSED MERGER WITH JADE BIOSCIENCES
AEROVATE THERAPEUTICS INC - CASH DIVIDEND EXPECTED TO BE IN RANGE OF $67.6 - 69.6 MILLION
Source text: ID:nPn9bbfTsa
Further company coverage: AVTE.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.